In focus: Study backs Misight use in myopia management

Coopervision has released data from a five-year, two-part study into the effects of its Misight 1 day contact lenses on children with myopia.

Due to be published at the British Contact Lens Association (BCLA) Conference in late May but postponed until this month, Coopervision called the research the ‘world’s longest-running clinical trial involving children wearing contact lenses’. The company said its ‘landmark study’ came at precisely the right time as ‘optometrists, ophthalmologists and public health authorities are facing the growing worldwide severity and prevalence of progressive childhood myopia’.

‘The data and insights from this multi-year clinical trial are powerful, reinforcing the positive impact of this lens on myopic children,’ said Daniel McBride, president of Coopervision.